Oxford Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Oxford Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-601,182	Closed	-$45.1M	–	1057
2015 Q3	$45.1M	Buy	601,182 +300	+0%	+$22.4K	1.42%	13
2015 Q2	$45.3M	Buy	+600,882	New	+$32.2M	1.23%	12
2015 Q1	–	Sell	-39,243	Closed	-$1.37M	–	829
2014 Q4	$1.37M	Sell	39,243 -4,480	-10%	-$156K	0.03%	438
2014 Q3	$1.45M	Buy	43,723 +33,340	+321%	+$1.17M	0.03%	418
2014 Q2	$395K	Buy	10,383 +1,367	+15%	+$47.7K	0.01%	591
2014 Q1	$358K	Buy	+9,016	New	+$403K	0.01%	551
2013 Q4	–	Sell	-60,328	Closed	-$2.76M	–	894
2013 Q3	$2.76M	Buy	+60,328	New	+$1.8M	0.06%	375

Oxford Asset Management's KYTH Position: Q4 2015 in Review

Oxford Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 601,182 shares — an estimated $45.1M sold.

Oxford Asset Management first reported a position in KYTH in Q3 2013 and held it in 7 quarters. The position peaked at $45.3M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Oxford Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Oxford Asset Management sold 601,182 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $45.1M.
Oxford Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 7 quarters.
Oxford Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $45.3M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Oxford Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.